← Eichor
Condition: Central Centrifugal Cicatricial Alopecia Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Central Centrifugal Cicatricial Alopecia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
Phase 4 · 1 location(s) · Wake Forest University Health Sciences · NCT04207931
Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07487948
A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
NA · 1 location(s) · Wake Forest University Health Sciences · NCT04764331
Deucravacitinib in the Treatment of Cicatricial Alopecias
Phase 2 · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT07508488
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.